Valeo Financial Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5
| Closed | – | – | 1815 |
|
|
2021
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 2124 |
|
|
2020
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 1844 |
|
|
2020
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 2126 |
|
|
2020
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 2116 |
|
|
2020
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 1898 |
|
|
2019
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 1733 |
|
|
2019
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 1693 |
|
|
2019
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 1673 |
|
|
2019
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 1693 |
|
|
2018
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 1759 |
|
|
2018
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 1878 |
|
|
2018
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 1777 |
|
|
2018
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 1651 |
|
|
2017
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 1508 |
|
|
2017
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1227 |
|